FDA Expands Advisory Cmte. Disclosures As Congress Directs Conflict Reductions
Executive Summary
FDA's draft guidance on the procedure for disclosing conflicts of interest will extend the agency's disclosure policy to cover all advisory committee members
You may also be interested in...
FDA Amendments Act’s One-Year Anniversary: For Better Or Worse
At the one-year anniversary of the FDA Amendments Act, the agency's record is mixed in meeting its increased responsibilities and authorities the law requires
FDA Amendments Act’s One-Year Anniversary: For Better Or Worse
At the one-year anniversary of the FDA Amendments Act, the agency's record is mixed in meeting its increased responsibilities and authorities the law requires
Advisory Committee Vacancies Remain High As FDA Revs Up Search Efforts
With its recent hiring push drawing attention, FDA is quietly undertaking another recruitment effort - filling advisory committee roster vacancies